Copyright
©The Author(s) 2018.
World J Gastroenterol. May 28, 2018; 24(20): 2181-2190
Published online May 28, 2018. doi: 10.3748/wjg.v24.i20.2181
Published online May 28, 2018. doi: 10.3748/wjg.v24.i20.2181
Figure 1 Indoleamine-2,3-dioxygenase 1, cyclooxygenase 2, CD3 and CD8 expression in colorectal cancer.
A: Examples of the tumoral staining intensity (0, 1+, 2+ and 3+) of IDO1 in immunohistochemistry analysis; B: Examples of the tumoral staining intensity (0, 1+, 2+ and 3+) of COX2 in immunohistochemistry analysis; C: Representative examples of tumors with intraepithelial CD3 and CD8 scores (1+, 2+, 3+ and 4+). CRC: Colorectal cancer; COX2: Cyclooxygenase 2; IDO1: Indoleamine-2,3-dioxygenase 1.
- Citation: Ma WJ, Wang X, Yan WT, Zhou ZG, Pan ZZ, Chen G, Zhang RX. Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer. World J Gastroenterol 2018; 24(20): 2181-2190
- URL: https://www.wjgnet.com/1007-9327/full/v24/i20/2181.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i20.2181